1. Home
  2. FGBI vs NYXH Comparison

FGBI vs NYXH Comparison

Compare FGBI & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

SELL

Current Price

$7.95

Market Cap

134.1M

Sector

Finance

ML Signal

SELL

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$1.25

Market Cap

137.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FGBI
NYXH
Founded
1934
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.1M
137.5M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
FGBI
NYXH
Price
$7.95
$1.25
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $4.20
AVG Volume (30 Days)
21.2K
★ 147.9K
Earning Date
11-16-2026
11-05-2026
Dividend Yield
★ 0.49%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.31
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$275.91
Revenue Next Year
N/A
$93.27
P/E Ratio
$26.10
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.31
$1.26
52 Week High
$11.02
$6.08

Technical Indicators

Market Signals
Indicator
FGBI
NYXH
Relative Strength Index (RSI) 43.54 37.89
Support Level $8.01 N/A
Resistance Level $8.88 $1.69
Average True Range (ATR) 0.35 0.07
MACD -0.00 -0.01
Stochastic Oscillator 21.37 3.45

Price Performance

Historical Comparison
FGBI
NYXH

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana through several banking facilities. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and, to a lesser extent, consumer and multifamily loans. The company is engaged in a single line of business as a financial institution, which provides a full range of banking, financial, and trust services to state, county, and local government entities, individuals, and small and commercial businesses.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: